공시 • May 11
Clariant AG Provides Earnings Guidance for the Year 2026 Clariant AG provided earnings guidance for the year 2026. For the year, the guidance remains unchanged, with sales expected to be around 2025 levels in local currency. The Middle East conflict is mainly impacting Catalysts customers in the Middle East and Asia, with sales now expected to be below the prior year. At the same time, expect growth in Adsorbents & Additives, as well as continued slight underlying growth in Care Chemicals, despite the Middle East impacts in Oil Services and increasing risks on the overall demand environment. To mitigate the inflation in raw materials and energy, they activated proven value-based price management and further continue focus on cost initiatives. By leveraging global network and employing proactive logistics they provide continued supply for customers. 공시 • Mar 09
Clariant AG, Annual General Meeting, Apr 01, 2026 Clariant AG, Annual General Meeting, Apr 01, 2026, at 09:30 W. Europe Standard Time. Reported Earnings • Mar 01
Full year 2025 earnings released: CHF0.23 loss per share (vs CHF0.74 profit in FY 2024) Full year 2025 results: CHF0.23 loss per share (down from CHF0.74 profit in FY 2024). Revenue: CHF3.92b (down 5.7% from FY 2024). Net loss: CHF75.0m (down 131% from profit in FY 2024). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Europe. New Risk • Feb 04
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Austrian stocks, typically moving 5.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (5.6% average weekly change). Minor Risks Dividend is not well covered by earnings (122% payout ratio). Large one-off items impacting financial results. 공시 • Feb 04
Henkel AG & Co. KGaA (XTRA:HEN3) entered into an agreement to acquire Stahl Parent B.V. from Wendel (ENXTPA:MF), BASF SE (XTRA:BAS), Clariant AG (SWX:CLN) and others for an enterprise value of €2.1 billion. Henkel AG & Co. KGaA (XTRA:HEN3) entered into an agreement to acquire Stahl Parent B.V. from Wendel (ENXTPA:MF), BASF SE (XTRA:BAS), Clariant AG (SWX:CLN) and others for an enterprise value of €2.1 billion on February 4, 2026. In addition to Wendel with 68.5% of the capital, BASF with 6.1% of the capital, Clariant with 14.6% of the capital and other minority shareholders will also sell their interests in Stahl to Henkel. The contemplated transaction values Stahl at a level that would yield total net proceeds at completion (after debt and transaction costs) of €1.2 billion for Wendel. This corresponds to a multiple of 6.6 times (net) Wendel’s total investment since 2006, including €427 million of past proceeds thanks to Stahl’s robust cash generation. After the acquisition Henkel AG & Co. KGaA owns 100% stake in Stahl Parent B.V.
Stahl employs around 1,700 employees and generated adjusted sales of approximately €725 million in fiscal year 2025 with a balanced regional footprint.
The transaction is subject to mandatory consultation processes and the satisfaction of customary closing conditions, including regulatory approvals. 공시 • Jan 13
Clariant AG to Report Q3, 2026 Results on Nov 03, 2026 Clariant AG announced that they will report Q3, 2026 results on Nov 03, 2026 공시 • Dec 20
CMV Química, C.A. acquired Clariant Venezuela S.A. from Clariant AG (SWX:CLN) for CHF 1.4 million. CMV Química, C.A. acquired Clariant Venezuela S.A. from Clariant AG (SWX:CLN) for CHF 1.4 million on December 19, 2025. For the period ending December 31, 2024, Clariant Venezuela S.A. reported total revenue of CHF 3 million and employed around 60 people..
CMV Química, C.A. completed the acquisition of Clariant Venezuela S.A. from Clariant AG (SWX:CLN) for CHF 1.4 million on December 19, 2025. 공시 • Dec 01
Clariant AG Announces Executive and Board Committee Changes Clariant announced a planned leadership transition within its Business Unit Care Chemicals upon the retirement of Christian Vang in 2026. Marcelo Lu will join Clariant in January 2026 as President Designate for Care Chemicals & Americas and will be a member of the Executive Steering Committee. For the first six months, he will be based at Clariant’s global headquarters in Pratteln, Switzerland, where he will contribute to Group-level priorities and collaborate closely with senior leaders across the organization. During this period, Christian Vang will continue to lead Care Chemicals as President, ensuring continuity and focus on strategic goals. Marcelo Lu launched his career at BASF in 2006 and has held various commercial and general management positions in Germany, Hong Kong, Canada, the U.S and Singapore. His roles included serving as the President of BASF Canada Inc. from 2016 to 2021, and subsequently as the Senior Vice President, Care Chemicals North America at BASF Corporation. In 2024, he was appointed to his current role as President of BASF Asia Pacific (excluding China) & Non-Executive Director BASF India Ltd., based in Singapore. Christian began his career at Clariant in February 2008 as the regional Head of Asia Pacific. He has held several key positions within the organization. In 2022 he was appointed President for Care Chemicals & Americas and Member of the Executive Steering Committee. 공시 • Oct 30
Clariant AG Confirms Earnings Guidance for the Year 2025 Clariant AG confirmed earnings guidance for the year 2025. For the year, the company expected local currency sales growth at the lower end of the 1% to 3% range .